康芝药业：股东宏氏投资将部分股份办理解除质押和再质押

Core Viewpoint - Kangzhi Pharmaceutical announced that its controlling shareholder, Hongshi Investment, will handle the release and re-pledging of part of its shares in the company [2] Group 1 - The announcement was made on the evening of September 4 [2] - The action involves the shares held by the controlling shareholder, indicating potential changes in ownership structure or liquidity management [2]